Randi Isaacs
Chief Tech/Sci/R&D Officer at WEREWOLF THERAPEUTICS, INC.
Net worth: - $ as of 30/04/2024
Randi Isaacs active positions
Companies | Position | Start | End |
---|---|---|---|
WEREWOLF THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2020 | - |
Career history of Randi Isaacs
Former positions of Randi Isaacs
Companies | Position | Start | End |
---|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Director/Board Member | 01/08/2015 | 01/11/2020 |
C4 THERAPEUTICS, INC. | Director/Board Member | 01/05/2021 | - |
University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - | - |
The State University of New York | Corporate Officer/Principal | - | - |
Training of Randi Isaacs
Wellesley College | Undergraduate Degree |
Dartmouth Medical School | Graduate Degree |
Statistics
International
United States | 8 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Consumer Services | 5 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
WEREWOLF THERAPEUTICS, INC. | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Randi Isaacs
- Experience